IPN-01195
- Generic Name
- IPN-01195
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 85
- Registration Number
- NCT06833008
- Locations
- 🇫🇷
Centre Léon Bérard - Lyon, Lyon, France
🇫🇷Paris Saint-Louis, Paris, France
🇫🇷IGR-Villejuif, Villejuif, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath